Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis

Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of non-Hodgkin’s lymphomas with poor clinical outcomes. Pralatrexate showed efficacy and safety in recurrent or refractory PTCLs. The purpose or this study was to investigate the efficacy and safety of pralatrexate in relapsed or refractor...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Hong, Jung Yong, Yoon, Dok Hyun, Yoon, Sang Eun, Kim, Seok Jin, Lee, Ho Sup, Eom, Hyeon-Seok, Lee, Hye Won, Shin, Dong-Yeop, Koh, Youngil, Yoon, Sung-Soo, Jo, Jae-Cheol, Kim, Jin Seok, Kim, Soo-Jeong, Cho, Su-Hee, Lee, Won-Sik, Won, Jong-Ho, Kim, Won Seog, Suh, Cheolwon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6937326/
https://ncbi.nlm.nih.gov/pubmed/31889144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-56891-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia